91.9
Spruce Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
83.6
FY23:
102
FY24:
44.2
FY25:
52.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
34.6
FY22:
2.04
FY23:
1.76
FY24:
1.00
FY25:
0.91
Total assets
Change from FY21 to FY25
millions USD
FY21:
126
FY22:
85.6
FY23:
104
FY24:
45.2
FY25:
53.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.87
FY22:
12.4
FY23:
24.5
FY24:
15.2
FY25:
10.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.24
FY22:
4.72
FY23:
2.97
FY24:
1.14
FY25:
0.42
(positive)
Change from FY21 to FY25
millions USD
FY21:
111
FY22:
68.5
FY23:
76.5
FY24:
28.8
FY25:
42.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
126
FY22:
85.6
FY23:
104
FY24:
45.2
FY25:
53.0
All amounts in millions USD